SCHEMBL4032625

SCHEMBL4032625

NN1C(=O)NC(=O)C12Cc1ccccc1C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
QPCT Q16769 1/20 0.43
AKR1B1 P15121 1/20 0.36
AHR P35869 1/20 0.34
PDK2 Q15119 1/20 0.34
BRD4 O60885 1/20 0.34
CREBBP Q92793 1/20 0.34
CALCRL Q16602 5/20 0.33
NPC1 O15118 1/20 0.33
MAPK13 O15264 1/20 0.33
MAPK12 P53778 1/20 0.33
MAPK11 Q15759 1/20 0.33
MAPK14 Q16539 1/20 0.33
TDP2 O95551 1/20 0.32
CASP3 P42574 1/20 0.32
CASP7 P55210 1/20 0.32
CASP9 P55211 1/20 0.32
CASP6 P55212 1/20 0.32
CASP8 Q14790 1/20 0.32
MAP3K14 Q99558 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL379723 0.77 CALCRL (0.46) QPCTBRD4CREBBPCALCRL
SCHEMBL5534441 0.70 DDB1 (0.41) QPCTCASP7MAPTALDH1A1POLB
SCHEMBL4700125 0.67 ATM (0.38) QPCTCALCRLALDH1A1
SCHEMBL379605 0.66 BRD4 (0.35) BRD4CREBBPMAPTALDH1A1KDM4E
SCHEMBL4032622 0.65 ALDH1A1 (0.47) AHRPDK2BRD4CREBBPNPC1
SCHEMBL14353736 0.64 ALDH1A1 (0.42) AKR1B1CYP1A2MAPTALDH1A1POLB
SCHEMBL1274913 0.62 CALCRL (0.46) CALCRL
SCHEMBL1394328 0.62 CALCRL (0.46) CALCRL
SCHEMBL259592 0.61 CRBN (0.44) AHRPDK2CALCRLNPC1MAPK13
SCHEMBL1986924 0.60 MAPT (0.40) AKR1B1BRD4CREBBPMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049532-A1 CGRP RECEPTOR ANTAGONISTS Vertex Pharmaceuticals, Inc. (US) 2009-04-22 EP disclosed
WO-2008011190-A1 CGRP RECEPTOR ANTAGONISTS VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-01-24 WO disclosed
EP-1608627-A4 BICYCLIC ANILIDE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2007-08-01 EP disclosed
EP-1608627-A2 BICYCLIC ANILIDE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS Merck & Co. Inc. (US) 2005-12-28 EP disclosed
WO-2004082605-A2 BICYCLIC ANILIDE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS MERCK & CO. INC. (US) 2004-09-30 WO disclosed